Apple has been lagging as other mega-cap tech stocks trad…

Apple has been lagging as other mega-cap tech stocks trad...

Business

American City Business Journals

Could P&G bid for Bristol-Myers Squibb unit?

Bristol-Myers Squibb is considering the sale of its UPSA consumer health care division in France, and Procter & Gamble Co. could be among interested bidders. The deal added the Clairol, Aussie and Herbal Essences brands to P&G, which divested of the Clairol brand in 2016 as part of a deal with Coty. Inc. However, P&G declined to comment on whether it might like to buy UPSA, which stands for Union Pharmacologique Scientifique Appliquee.  “As a matter of practice, we don’t comment on market speculation or rumor as it relates to M&A strategy,” P&G spokesman Damon Jones told me.   The UPSA unit of Bristol-Myers Squibb, which the New York-based firm acquired in 1994, reportedly could sell for $1.8 billion.

Read on The Source

Share:

Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on The Latest News on Wall Street, Stocks, #Politics and Business news. Hedge Accordingly produces both original, and aggregated #Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About HEDGEaccordingly.com